Mr. Kasim Kutay is a Chief Executive Officer at Novo Holdings A/S, Novo Holdings A/S and at Novo Principal Investments.
He is on the Board of Directors at Novo Nordisk A/S, Novozymes A/S and Evotec SE.
From 2009 to 2016 he was managing director, co-head of Europe and member of the Global Management Committee of Moelis & Co., UK. From 1989 to 2007 Mr Kutay held a number of positions at Morgan Stanley, UK, including chair of the European Healthcare Group.
Mr. Kutay was member of the Board of Trustees of Northwick Park Institute for Medical Research, UK, from 2005 to 2016.
Mr. Kutay was member of the Board of Governors from 2006 to 2011 and the Investment Committee from 2011 to 2016 of the School of Oriental and African Studies (SOAS), UK.
He received his undergraduate degree from London School of Economics & Political Science and a graduate degree from London School of Economics & Political Science.